NCT03582267View on ClinicalTrials.gov

The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2019

Conditions
Head Trauma
Interventions
DIETARY_SUPPLEMENT

Docosahexaenoic Acid (DHA)

Daily administration of docosahexaenoic Acid (DHA). 2 grams of DHA liquid concentrate administered per day throughout trial period.

Trial Locations (1)

76129

Texas Christian Universti, Fort Worth

All Listed Sponsors
lead

Texas Christian University

OTHER

NCT03582267 - The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players | Biotech Hunter | Biotech Hunter